Inventor · disambiguated record
Michael Firnges
Also filed as: FIRNGES MICHAEL
5 granted patents·4 pending applications·2 citations·filing 2005–2007
61Inventor score
Top patents by PatentIndex Score
9 records- 0176US7763607B2Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulatorsSOLVAY PHARM GMBH·Filed 2007·Granted Jul 27, 2010·1 cites·17 claims
- 0261US8058264B2Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditionsFIRNGES MICHAEL·Filed 2005·Granted Nov 15, 2011·1 cites·25 claims
- 0354US2007254863A1Use of CBx cannabinoid receptor modulators as potassium channel modulatorsANTEL JOCHEN·Filed 2007·Application pending·0 cites
- 0448US7592344B2NK1 and NK2-antagonists and compositions and methods of using the sameSOLVAY PHARM GMBH·Filed 2006·Granted Sep 22, 2009·0 cites·16 claims
- 0547US2005261292A1Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 0644US7772225B2N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2006·Granted Aug 10, 2010·0 cites·18 claims
- 0744US2007219214A1Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparationSOLVAY PHARM GMBH·Filed 2007·Application pending·0 cites
- 0841US7547708B2N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereofSOLVAY PHARMACEUTICALS INC·Filed 2006·Granted Jun 16, 2009·0 cites·20 claims
- 0941US2007191357A1Methods of using potassium channel inhibiting compoundsANTEL JOCHEN·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →